» Articles » PMID: 9874792

Polyglutamine-mediated Dysfunction and Apoptotic Death of a Caenorhabditis Elegans Sensory Neuron

Overview
Specialty Science
Date 1999 Jan 6
PMID 9874792
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of expressing human huntingtin fragments containing polyglutamine (polyQ) tracts of varying lengths was assessed in Caenorhabditis elegans ASH sensory neurons in young and old animals. Expression of a huntingtin fragment containing a polyQ tract of 150 residues (Htn-Q150) led to progressive ASH neurodegeneration but did not cause cell death. Progressive cell death and enhanced neurodegeneration were observed in ASH neurons that coexpressed Htn-Q150 and a subthreshold dose of a toxic OSM-10::green fluorescent protein (OSM-10::GFP) fusion protein. Htn-Q150 huntingtin protein fragments formed protein aggregates in ASH neurons, and the number of ASH neurons containing aggregates increased as animals aged. ASH neuronal cell death required ced-3 caspase function, indicating that the observed cell death is apoptotic. Of interest, ced-3 played a critical role in Htn-Q150-mediated neurodegeneration but not in OSM10::GFP-mediated ASH neurodegeneration. ced-3 function was important but not essential for the formation of protein aggregates. Finally, behavioral assays indicated that ASH neurons, coexpressing Htn-Q150 and OSM10::GFP, were functionally impaired at 3 days before the detection of neurodegeneration, cell death, and protein aggregates.

Citing Articles

Downregulation of Pten Improves Huntington's Disease Phenotype by Reducing Htt Aggregates and Cell Death.

Nisha , Thapliyal D, Gohil B, Modak A, Singh N, Mukherjee C Mol Neurobiol. 2025; .

PMID: 40042729 DOI: 10.1007/s12035-025-04816-6.


Lipid Oxidation at the Crossroads: Oxidative Stress and Neurodegeneration Explored in .

Tortajada-Perez J, Carranza A, Trujillo-Del Rio C, Collado-Perez M, Millan J, Garcia-Garcia G Antioxidants (Basel). 2025; 14(1).

PMID: 39857412 PMC: 11762898. DOI: 10.3390/antiox14010078.


Quinic acid protects against the development of Huntington's disease in Caenorhabditis elegans model.

El Din R, Thabit S BMC Complement Med Ther. 2024; 24(1):377.

PMID: 39468600 PMC: 11514749. DOI: 10.1186/s12906-024-04670-4.


Olfactory dysfunction as an early pathogenic indicator in models of Alzheimer's and polyglutamine diseases.

Xue W, Lei Z, Liu B, Guo H, Yan W, Jin Y Front Aging Neurosci. 2024; 16:1462238.

PMID: 39411283 PMC: 11473296. DOI: 10.3389/fnagi.2024.1462238.


Towards Understanding Neurodegenerative Diseases: Insights from .

Wu Y, Chen Y, Yu X, Zhang M, Li Z Int J Mol Sci. 2024; 25(1).

PMID: 38203614 PMC: 10778690. DOI: 10.3390/ijms25010443.


References
1.
Hart A, Sims S, Kaplan J . Synaptic code for sensory modalities revealed by C. elegans GLR-1 glutamate receptor. Nature. 1995; 378(6552):82-5. DOI: 10.1038/378082a0. View

2.
Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G . Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 1995; 378(6555):403-6. DOI: 10.1038/378403a0. View

3.
Persichetti F, Ambrose C, Ge P, McNeil S, Srinidhi J, Anderson M . Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. Mol Med. 1995; 1(4):374-83. PMC: 2230005. View

4.
Mello C, Fire A . DNA transformation. Methods Cell Biol. 1995; 48:451-82. View

5.
Gusella J, Macdonald M . Huntington's disease: CAG genetics expands neurobiology. Curr Opin Neurobiol. 1995; 5(5):656-62. DOI: 10.1016/0959-4388(95)80072-7. View